Building Your MDL 3140 Portfolio with Precision
March 16, 2026 by Mohr Marketing

Safeguarding Your Firm’s Depo-Provera (MDL 3140) Inventory

As the pharmaceutical liability landscape shifts toward MDL 3140 (In re: Depo-Provera Products Liability Litigation), many firms are facing a critical operational choice: build volume quickly or build volume correctly.

While the potential plaintiff pool for Depo-Provera is massive—estimated at 74 million women worldwide—the clinical criteria required to survive a Daubert challenge are exceptionally specific. Somewhere between the latest filings and the industry’s focus on other dockets, a “silent risk” has emerged: intake noise.

At Mohr Marketing, we recognize that your firm cannot afford to fill its inventory with “headache” calls or unrelated conditions like glioblastomas. That is why we deployed our proprietary Compliance Shield protocol specifically for the Depo-Provera docket.

As detailed in the attached Firm Comparison Sheet, our protocol ensures every retainer we deliver meets the rigorous standards established by the March 2024 BMJ study:

  • Usage Duration Verification: We strictly enforce the “1-Year Rule,” rejecting any cases with fewer than 12 months of cumulative use.
  • Specific Injury Validation: We screen exclusively for imaging-confirmed Intracranial Meningiomas, filtering out non-compensable neurological conditions.
  • Regulatory & Fraud Defense: Every lead is audit-ready, featuring TrustedForm/Jornaya certification and real-time Scammer Scrub™ technology to ensure 100% TCPA compliance.

With discovery ongoing and bellwether trials expected by late 2026, the window to acquire high-quality, verified cases against a solvent defendant like Pfizer is open now.

Ready to fill your docket with valid cases?

Partner with Mohr Marketing to secure high-quality, compliant plaintiffs.

Contact Mohr Marketing to deploy the Compliance Shield today.

Click Here Get a Custom Quote

Read Press Release

Let’s discuss your specific needs and how our Compliance Program, AI Lead Generation Technology, digital marketing, and mass tort cases can help you achieve your growth goals.

www.mohrmktg.com 

Mohr Marketing Team

Summary
Building Your MDL 3140 Portfolio with Precision
Article Name
Building Your MDL 3140 Portfolio with Precision
Description
As the pharmaceutical liability landscape shifts toward MDL 3140 (In re: Depo-Provera Products Liability Litigation), many firms are facing a critical operational choice: build volume quickly or build volume correctly.
Author
Publisher Name
Mohr Marketing, LLC
Publisher Logo
Spread the love
Secret Link